Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 9.52M P/E - EPS this Y 80.30% Ern Qtrly Grth -
Income -9.84M Forward P/E - EPS next Y - 50D Avg Chg -8.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -28.00%
Dividend N/A Price/Book 0.87 EPS next 5Y - 52W High Chg -60.00%
Recommedations 2.00 Quick Ratio 0.82 Shares Outstanding 15.67M 52W Low Chg 15.00%
Insider Own 8.51% ROA -53.57% Shares Float 12.09M Beta 1.03
Inst Own 16.80% ROE -111.99% Shares Shorted/Prior 352.65K/76.83K Price 0.82
Gross Margin - Profit Margin - Avg. Volume 977,687 Target Price -
Oper. Margin - Earnings Date - Volume 29,182 Change -0.39%
About Sharps Technology Inc.

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

Sharps Technology Inc. News
03/07/24 Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems
02/21/24 Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia
02/16/24 Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems
01/18/24 Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems
09/29/23 Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.6 Million Registered Direct & Private Placement Priced at the Market Under Nasdaq Rules for Sharps Technology, Inc. (NASDAQ: STSS)
09/29/23 Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement
09/29/23 Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
09/28/23 Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals
09/27/23 UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
09/27/23 Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules
09/26/23 Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals
09/22/23 Sharps Technology, Inc. CEO is Featured in an Interview with SmallCapsDaily
08/02/23 RedChip Launches 'Small Stocks, Big Money' Podcast
07/12/23 Sharps Technology Appoints Industry Sales and Manufacturing LeaderΒ Ben Scheu as Senior Director of Sales
07/06/23 Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article
05/19/23 Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
05/06/23 We Might See A Profit From Sharps Technology, Inc. (NASDAQ:STSS) Soon
STSS Chatroom

User Image alejajcucha Posted - 19 hours ago

$STSS any update here???? πŸš€πŸš€πŸš€

User Image FastFreddy69 Posted - 23 hours ago

$STSS

User Image alejajcucha Posted - 2 days ago

$STSS can we get positive PR here? πŸš€πŸš€πŸš€

User Image estockse Posted - 2 days ago

$STSS https://ow.ly/AetH50Rgvpx

User Image confucius_trader Posted - 2 days ago

$STSS why!!!!!! Ugh. Need some actual valuation here.

User Image estockse Posted - 3 days ago

@zdp2 I do like your optimism and hope that are correct on $STSS. In support of you I am also "bullish" without a good reason though as the management has stopped communicating with shareholders and has not declared any revenue impacting design wins. I hope for the best but at this time "hope" is not a good guidance. So, let's say "bullish" and "worrying a lot!".

User Image Jabed206 Posted - 5 days ago

$STSS sole backer... Aegis Capital Corp... crooks. Company worth nothing...

User Image Jabed206 Posted - 5 days ago

$STSS Aegis Capital Corp stock!!

User Image peterpan124 Posted - 5 days ago

$STSS better think of a good fluff story to go with rs 4:1 if they want to stay over a dollar They will have to vote for a larger RS because they will need to raise money too.

User Image FastFreddy69 Posted - 6 days ago

$STSS

User Image peterpan124 Posted - 1 week ago

$STSS so many things could happen but aren't Cash burn heading for desist dilution RS 🫠🫠🫠🫠🫠

User Image Hendwey Posted - 1 week ago

$STSS Just when I think I might get my money back. I get the rug pulled out from under me.πŸ“ˆπŸ€”πŸ˜πŸ“‰πŸ“‰πŸ“‰πŸ™„

User Image ZdP2 Posted - 1 week ago

$STSS

User Image Freeeway Posted - 1 week ago

$STSS cash burn will come to roost in July. Some unhappy shareholders. Where’s 3 years of money gone - salaries, bonuses, shares, admin but no sales. Didnt front to shateholders in March - let’s see this month. Youve got to work hard to achieve a delisting.

User Image BiotechBreakout Posted - 1 week ago

$STSS it held up well in a very red market.

User Image FastFreddy69 Posted - 1 week ago

$STSS After-hours

User Image 1Mediocre Posted - 1 week ago

$STSS Patiently waiting for the meeting at the end of the month! Updates and news!!

User Image FastFreddy69 Posted - 2 weeks ago

$STSS

User Image alejajcucha Posted - 2 weeks ago

$STSS waiting for $3 πŸš€πŸš€πŸš€

User Image ChiefOG Posted - 2 weeks ago

$STSS 🧐

User Image ZdP2 Posted - 2 weeks ago

$RVP 30M$ market cap is overvalued imho. Have a look at $STSS, fresh company in the same industry, about to become a serious competitor for RVP. Their design is also way more elegant. RVP already had to withdraw a batch : "The recall is due to the possible detachment of the needle cannula from the needle holder, which could result in serious injury." This is simply because of the clumsy design of these needles. With the design of STSS that can't happen. Jmho, not financial advice ;-)

User Image ZdP2 Posted - 2 weeks ago

$STSS Zoom call end of this month, don't miss it πŸ˜‰

User Image Scooter0619 Posted - 2 weeks ago

$STSS RedChip plugging STSS. For 2024 $ 59.7 million in revenue and $17.2 in EBITDA. Really, what a joke.

User Image alejajcucha Posted - 2 weeks ago

$STSS bullish πŸš€πŸš€πŸš€

User Image ZdP2 Posted - 2 weeks ago

$STSS Just a little push and we break out of this descending channel to hit the 200D MA. I have some decent hope that this will happen within a month from now. Only 3 more weeks until the Zoom meeting with Robert.

User Image ZdP2 Posted - 2 weeks ago

$STSS 8K volume πŸ˜… We might be stuck here until we get some news.

User Image peterpan124 Posted - 2 weeks ago

$STSS https://ir.sharpstechnology.com/sharps-technology-announces-letter-to-shareholders/ Did we sell 100 million yet?!???🫠🫠🫠

User Image alejajcucha Posted - 3 weeks ago

$STSS bullish πŸš€πŸš€πŸš€

User Image Benzinga Posted - 3 weeks ago

Sharps Technology's Global Expansion: Achieving Key Milestones To Strengthen Market Position $STSS https://www.benzinga.com/partner/biotech/24/04/38045550/sharps-technologys-global-expansion-achieving-key-milestones-to-strengthen-market-position

User Image ZdP2 Posted - 3 weeks ago

$STSS Reached out to Robert Hayes, asked him why the call was postponed. He responded they are currently still in discussions about several projects. Postponing the meeting will allow him to discuss (and give a more accurate status update on) these projects.

Analyst Ratings
Aegis Capital Buy May 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Jan 31 Buy 0.37 10,200 3,774 75,882 02/05/24
Ruemler Timothy James Director Director Jan 02 Buy 0.4 9,466 3,786 1,061,675 01/04/24
Crescenzo Andrew R. Chief Financial Offi.. Chief Financial Officer Dec 28 Buy 0.4216 3,500 1,476 15,500 12/29/23
Ruemler Timothy James Director Director Dec 22 Buy 0.4016 10,000 4,016 1,052,209 12/22/23
Ruemler Timothy James Director Director Nov 22 Buy 0.45 10,000 4,500 1,042,209 11/27/23
Ruemler Timothy James Director Director Nov 17 Buy 0.41 15,000 6,150 1,022,209 11/21/23
Ruemler Timothy James Director Director Nov 15 Buy 0.41 6,000 2,460 1,017,209 11/17/23
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Apr 14 Buy 1.28 4,000 5,120 65,682 04/18/23
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Mar 13 Buy 1.36 5,100 6,936 61,682 03/15/23
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Feb 17 Buy 1.36 3,500 4,760 56,582 02/22/23
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Sep 02 Buy 1.35 5,000 6,750 53,082 09/07/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Aug 30 Buy 1.35 8,073 10,899 48,082 09/01/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Aug 26 Buy 1.41 4,009 5,653 40,009 08/30/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Aug 22 Buy 1.29 4,000 5,160 36,000 08/24/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Aug 04 Buy 1.15 2,000 2,300 32,000 08/08/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer May 20 Buy 1.21 5,000 6,050 25,000 05/23/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Apr 27 Buy 1.48 4,000 5,920 14,000 05/02/22
Blackman Alan R. CIO and COO CIO and COO Apr 22 Buy 1.52 5,000 7,600 728,429 04/25/22
Ruemler Timothy James Director Director Apr 14 Buy 4.25 29,400 124,950 890,406 04/18/22
Hayes Robert Michael Chief Executive Offi.. Chief Executive Officer Apr 14 Buy 2.06 7,000 14,420 7,000 04/18/22
Blackman Alan R. CIO and COO CIO and COO Apr 14 Buy 4.25 4,000 17,000 723,429 04/18/22